- Q4 2023 WAVE Life Sciences Ltd Earnings Call TranscriptMar 06, 2024$6.29 (+31.32%)Earnings
- WAVE Life Sciences Ltd at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 WAVE Life Sciences Ltd Earnings Call TranscriptNov 09, 2023$5.21 (-9.55%)Earnings
- WAVE Life Sciences Ltd R&D Day TranscriptSep 28, 2023
- Q2 2023 WAVE Life Sciences Ltd Earnings Call TranscriptAug 03, 2023$5.06 (+15.79%)Earnings
- WAVE Life Sciences Ltd FOCUS-C9 Clinical Trial Results Conference Call TranscriptMay 23, 2023
- Q1 2023 WAVE Life Sciences Ltd Earnings Call TranscriptMay 03, 2023$3.75 (+1.90%)Earnings
- Q4 2022 WAVE Life Sciences Ltd Earnings Call TranscriptMar 22, 2023$3.8 (-10.38%)Earnings
- WAVE Life Sciences Ltd WVE-N531 Clinical Trial Update Call TranscriptDec 19, 2022
- WAVE Life Sciences Ltd Business Update TranscriptDec 13, 2022
- Q3 2022 WAVE Life Sciences Ltd Earnings Call TranscriptNov 10, 2022$4.17 (+5.84%)Earnings
- WAVE Life Sciences Ltd Investor Event TranscriptSep 28, 2022
- WAVE Life Sciences Ltd SELECT-HD Clinical Trial Update TranscriptSep 20, 2022
- Q2 2022 WAVE Life Sciences Ltd Earnings Call TranscriptAug 11, 2022$2.98 (+16.86%)Earnings
- WAVE Life Sciences Ltd at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Q1 2022 WAVE Life Sciences Ltd Earnings Call TranscriptMay 12, 2022$1.29 (-12.24%)Earnings
- WAVE Life Sciences Ltd Genetic Medicines and Cell Therapy Manufacturing Summit TranscriptApr 26, 2022
- WAVE Life Sciences Ltd to Discuss the FOCUS-C9 Clinical Trial Update Investor Call TranscriptApr 04, 2022
- WAVE Life Sciences Ltd at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Q4 2021 WAVE Life Sciences Ltd Earnings Call TranscriptMar 03, 2022$2.39 (-2.85%)Earnings
- Q3 2021 WAVE Life Sciences Ltd Earnings Call TranscriptNov 10, 2021$4.69 (+0.43%)Earnings
- WAVE Life Sciences Ltd Analyst And Investor Research Corporate Call TranscriptSep 28, 2021
- Q2 2021 WAVE Life Sciences Ltd Earnings Call TranscriptAug 05, 2021$6.03 (+8.65%)Earnings
- Q1 2021 WAVE Life Sciences Ltd Earnings Call TranscriptMay 13, 2021$5.86 (-4.25%)Earnings
- WAVE Life Sciences Ltd PRECISION-HD Trial Results and Business Update Call TranscriptMar 29, 2021
- Q4 2020 WAVE Life Sciences Ltd Earnings Call TranscriptMar 04, 2021$9.34 (-8.79%)Earnings
- WAVE Life Sciences Ltd at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- WAVE Life Sciences Ltd at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2020
- Q3 2020 WAVE Life Sciences Ltd Earnings Call TranscriptNov 09, 2020$7.48 (+3.60%)Earnings
- Wave Life Sciences Ltd. - Shareholder/Analyst Call TranscriptAug 25, 2020
- Q2 2020 WAVE Life Sciences Ltd Earnings Call TranscriptAug 10, 2020$9.43 (+3.06%)Earnings
- Q1 2020 WAVE Life Sciences Ltd Earnings Call TranscriptMay 11, 2020$10.11 (+26.85%)Earnings
- Q4 2019 WAVE Life Sciences Ltd Earnings Call TranscriptMar 02, 2020$7.93 (-6.04%)Earnings
- WAVE Life Sciences Ltd Corporate Call TranscriptDec 30, 2019
- Wave Life Sciences Ltd Suvodirsen Update Conference Call TranscriptDec 16, 2019
- WAVE Life Sciences Ltd to Host Analyst and Investor Research Day TranscriptOct 07, 2019
WAVE Life Sciences Ltd WVE-N531 Clinical Trial Update Call Transcript
Good morning, and welcome to the Wave Life Sciences WVE-N531 proof-of-concept clinical trial conference call. (Operator Instructions) As a reminder, this call is being recorded and webcast.
I'll now turn the call over to Kate Rausch, Investor Relations at Wave Life Sciences. Please go ahead.
Thank you, operator. Good morning, and thank you for joining us today. I will be covering for Kate Rausch, while she's out on maternity leave. This morning, we issued a new release, providing an update on the initial cohort of our Phase Ib/IIa proof-of-concept clinical trial evaluating N531 as a potential treatment for Duchenne muscular dystrophy. A slide presentation to accompany this webcast is available at the Investor Relations section of our website at www.wavelifesciences.com. A replay will also be available on the website following today's call.
Before we begin, I would like to remind you that discussions during this conference call will include
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)